XBiotech Inc. (XBIT)Healthcare | Biotechnology | Austin, United States | NasdaqGS
2.46 USD
+0.03
(1.235%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.46 -0.03 (-0.027%) ⇩ (April 17, 2026, 4:10 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:32 p.m. EDT
XBIT is currently trading near its 52-week low, with a weak price momentum and negative earnings. The stock has a low dividend yield and no recent dividend history, making it unsuitable for income-focused investors. While the options market shows some bullish positioning, the fundamental weakness and negative earnings suggest caution. Short-term traders may consider buying calls if there is a breakout, but long-term investors should avoid due to the lack of fundamentals and high risk. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.137009 |
| AutoARIMA | 0.137535 |
| MSTL | 0.147206 |
| AutoTheta | 0.160931 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 1.27 |
| Ljung-Box p | 0.004 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 3.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2021-07-14 |
| Last Dividend Date | 2021-07-14 |
| Market Cap | 74,999,824 |
| Forward P/E | 18.92 |
| Beta | 0.83 |
| Website | https://www.xbiotech.com |
As of April 11, 2026, 1:32 p.m. EDT: Options speculators are showing mixed signals. Calls are positioned with higher open interest and implied volatility on the higher strike prices, indicating potential bullish sentiment for a significant price move. However, puts have higher implied volatility and open interest on the ATM strike, suggesting caution or bearish sentiment. The overall options activity suggests uncertainty, with traders hedging against potential downside or anticipating a sharp upward move.
| Date | Dividend | Yield % |
|---|---|---|
| 2021-07-15 | 2.5 | 15.087508 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.17171717 |
| Address1 | 5,217 Winnebago Lane |
| All Time High | 32.5 |
| All Time Low | 2.09 |
| Ask | 3.13 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 27,780 |
| Average Daily Volume3 Month | 39,148 |
| Average Volume | 39,148 |
| Average Volume10Days | 27,780 |
| Beta | 0.829 |
| Bid | 1.78 |
| Bid Size | 2 |
| Book Value | 4.603 |
| City | Austin |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.46 |
| Current Ratio | 16.011 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.5 |
| Day Low | 2.41 |
| Display Name | XBiotech |
| Dividend Date | 1,626,998,400 |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -53,999,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.936 |
| Enterprise Value | -50,551,180 |
| Eps Forward | 0.13 |
| Eps Trailing Twelve Months | -1.49 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,626,307,200 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 512 386 5505 |
| Fifty Day Average | 2.3471 |
| Fifty Day Average Change | 0.11290002 |
| Fifty Day Average Change Percent | 0.04810192 |
| Fifty Two Week Change Percent | -17.171717 |
| Fifty Two Week High | 3.61 |
| Fifty Two Week High Change | -1.1499999 |
| Fifty Two Week High Change Percent | -0.31855953 |
| Fifty Two Week Low | 2.09 |
| Fifty Two Week Low Change | 0.37000012 |
| Fifty Two Week Low Change Percent | 0.17703356 |
| Fifty Two Week Range | 2.09 - 3.61 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,429,104,600,000 |
| Float Shares | 19,091,722 |
| Forward Eps | 0.13 |
| Forward P E | 18.923079 |
| Free Cashflow | -26,277,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 85 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.36613998 |
| Held Percent Institutions | 0.076859996 |
| Implied Shares Outstanding | 30,487,732 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,626,307,200 |
| Last Dividend Value | 2.5 |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas. |
| Long Name | XBiotech Inc. |
| Market | us_market |
| Market Cap | 74,999,824 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_216818432 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -45,540,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 74,999,818 |
| Open | 2.41 |
| Operating Cashflow | -39,920,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 512 386 2900 |
| Post Market Change | -0.02699995 |
| Post Market Change Percent | -1.0856434 |
| Post Market Price | 2.46 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 2.43 |
| Price Hint | 4 |
| Price To Book | 0.5344341 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.88 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.029999971 |
| Regular Market Change Percent | 1.2345667 |
| Regular Market Day High | 2.5 |
| Regular Market Day Low | 2.41 |
| Regular Market Day Range | 2.41 - 2.5 |
| Regular Market Open | 2.41 |
| Regular Market Previous Close | 2.43 |
| Regular Market Price | 2.46 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 54,113 |
| Return On Assets | -0.19934 |
| Return On Equity | -0.28232 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 30,487,731 |
| Shares Percent Shares Out | 0.0047 |
| Shares Short | 144,176 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 108,774 |
| Short Name | XBiotech Inc. |
| Short Percent Of Float | 0.0075 |
| Short Ratio | 3.0 |
| Source Interval | 15 |
| State | TX |
| Symbol | XBIT |
| Total Cash | 125,551,000 |
| Total Cash Per Share | 4.118 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.49 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.600725 |
| Two Hundred Day Average Change | -0.1407249 |
| Two Hundred Day Average Change Percent | -0.054109875 |
| Type Disp | Equity |
| Volume | 54,113 |
| Website | https://www.xbiotech.com |
| Zip | 78,744 |